LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile observed in masked ...
She was 45, a mother of three, diagnosed with HER2-positive metastatic breast cancer.Her clinicians knew the standard of care. Monoclonal antibody therapies targeting HER2 have extended survival and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results